Related Experiment Video
Updated: Jun 1, 2026
12:45
Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
AV nodal ablation-induced Gerbode defect (LV-RA Shunt)
Ajay K Sharma1, Ravi Chander, Jagmeet P Singh
1Department of Internal Medicine, Charlton Memorial Hospital, Fall River, Massachusetts, USA.
Journal of Cardiovascular Electrophysiology
|June 9, 2011
Summary
A rare acquired Gerbode defect, a shunt between the left ventricle and right atrium, occurred after AV node ablation. This case highlights an unusual complication in patients with severe heart conditions.
Area of Science:
- Cardiology
- Cardiac Surgery
- Electrophysiology
Background:
- Gerbode defects, characterized by a left ventricular-to-right atrial shunt, are typically congenital.
- Acquired Gerbode defects are rare, with prior reports linked to endocarditis of the aortic or tricuspid valves.
Observation:
- A case of an acquired Gerbode defect is presented.
- The defect developed secondary to catheter ablation of the atrioventricular (AV) node.
Findings:
- The patient had a severely dilated cardiomyopathy and refractory atrial fibrillation.
- The Gerbode defect was a direct consequence of the AV node ablation procedure.
Implications:
- This case expands the known etiologies of acquired Gerbode defects.
- It underscores the potential for rare cardiac structural complications following electrophysiological procedures, even in the absence of endocarditis.
More Related Videos
Related Concept Videos
01:15Aortic Regurgitation I: Introduction
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
01:20Mitral Regurgitation I: Introduction
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
01:28Mitral Regurgitation IV: Nursing Management
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
01:17Aortic Regurgitation IV: Nursing Management
A nurse managing a patient with aortic regurgitation begins with a comprehensive assessment, including a review of the patient's medical history, family history, and lifestyle factors. During the cardiac examination, the nurse listens for heart sounds and checks for signs of valve abnormalities. The nurse also observes for symptoms such as dyspnea, orthopnea, and paroxysmal nocturnal dyspnea and assesses the patient's endurance and daily activity tolerance.Based on the findings, the nurse...
01:25Mitral Regurgitation III: Medical Management
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
01:25Aortic Regurgitation III: Medical Management
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...